PneumoADIP

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search

Pneumococcal vaccines Accelerated Development and Introduction Plan (PnemoADIP) is a small, dedicated team based at Johns Hopkins Bloomberg School of Public Health and is supported by a $30 million grant from the Global Alliance for Vaccines and Immunization. Its mission is to improve child survival and health by accelerating the evaluation of and access to new, lifesaving pneumococcal vaccines for the world's children.

PneumoADIP aims to achieve its goals through partnerships with countries, donors, academia, international organizations and industry. PneumoADIP coordinates its activities through a strategic alliance with the World Health Organization.

External link

  • PneumoADIP - Pneumococcal vaccines Accelerated Development and Introduction Plan

Template:Charity-org-stub


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools